# Progress Note 05 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Wilma Mankiller (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML052-SYN-TD
- Date: 1980-08-24
- Fictional facility: St. Posthumous Health Center
- Fictional author: Rena Hawkfeather-Lindqvist, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Preventive Visit
- Services: CPT 99395 (periodic preventive medicine, established patient, age 18 to 39) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Periodic preventive visit; no new complaints. **S**

## History of present illness

Ms. Mankiller, a 34-year-old woman with generalized myasthenia gravis, returns for her periodic preventive visit eleven weeks after robotic thymectomy. She completed the health risk assessment beforehand. Her eyelids no longer droop and double vision has not returned; she tires a little by late afternoon. She takes pyridostigmine 60 mg four times daily, prednisone (now 30 mg each morning and tapering), azathioprine 150 mg daily, trimethoprim-sulfamethoxazole three times a week, calcium and vitamin D. She sleeps less well on prednisone and has gained about 3 kg since the spring. She has had no breathlessness, swallowing trouble or infections. She is back at work most days and walks with a cane only on rough ground. She asks which vaccines and screening she needs while on these medicines. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit |
| Safety events | No falls, infections or emergency visits since the thymectomy |
| Medicines | Pyridostigmine 60 mg four times daily; prednisone 30 mg daily, tapering; azathioprine 150 mg daily; trimethoprim-sulfamethoxazole three times weekly; calcium carbonate and cholecalciferol |
| Active conditions | Generalized myasthenia gravis after thymectomy; autosomal dominant polycystic kidney disease with normal kidney function; recovery from major trauma |
| Functional status | Independent; cane on rough ground |

## Health risk assessment

Completed by the patient before the visit and reviewed during the visit. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good and improving |
| Psychosocial | Close ties to her community and work; the year since the crash has been hard; she has people to turn to |
| Tobacco | Never |
| Alcohol and drugs | None (AUDIT-C 0) |
| Physical activity | Walks most evenings; leg exercises from physical therapy three times a week |
| Nutrition | Home-cooked meals; less salt for her kidneys; more hungry on prednisone; drinks about 2.5 liters of water a day |
| Sleep | Wakes early on prednisone; about six hours |
| Safety at home | Feels safe at home; no violence or threats (screen negative) |
| Driving and seat belts | Always wears a seat belt; drives in daylight |
| Reproductive health | Not planning pregnancy; reports a reliable method of contraception, not recorded here |
| Sun exposure | Works outdoors at times; hat and sunscreen advised on azathioprine |
| Pain | Occasional aching in the left leg after long days |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Weight up about 3 kg on prednisone; mild late-afternoon tiredness; no fever |
| Eyes | Negative | No drooping eyelids or double vision |
| Ears, nose, mouth, and throat | Negative | No trouble chewing or swallowing; voice normal |
| Cardiovascular | Negative | No chest pain, palpitations or swelling |
| Respiratory | Negative | No breathlessness lying flat; cough strong |
| Gastrointestinal | Negative | Loose stools on pyridostigmine at times; no abdominal pain |
| Genitourinary | Negative | No blood in the urine, flank pain or urinary infections |
| Musculoskeletal | Positive | Occasional left leg ache after long days; no new joint pain |
| Integumentary | Negative | Healed thymectomy port sites; no new skin lesions |
| Neurological | Negative | No weakness of the arms or neck; no numbness |
| Psychiatric | Negative | Mood steady; sleep shorter on prednisone; PHQ-9 score 3 |
| Endocrine | Negative | No excess thirst or urination |

12 systems reviewed. **S**

## Current medications

- Pyridostigmine bromide 60 mg oral tablet, one tablet four times daily while awake, 30 to 45 minutes before meals **S**
- Prednisone 5 mg oral tablet, tapering from 40 mg each morning by 5 mg every two to three weeks **S**
- Azathioprine 50 mg oral tablet, one tablet daily for two weeks, then two tablets daily, then three tablets (150 mg, about 2.3 mg/kg) daily **S**
- Calcium carbonate 1250 mg (500 mg elemental calcium) oral tablet, one tablet daily with food **S**
- Cholecalciferol (vitamin D3) 1000 units (0.025 mg) oral tablet, one tablet daily **S**
- Sulfamethoxazole 800 mg / trimethoprim 160 mg oral tablet, one tablet three times a week, while prednisone is 20 mg or more with azathioprine **S**
- Acetaminophen 500 mg oral tablet, one or two tablets up to three times daily as needed for leg pain **S**

## Allergies

- No known allergy **S**

## Objective

BP 120/76 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 64.2 kg; BMI 24.2 kg/m². All vital signs are synthetic.

PHQ-9: 3; AUDIT-C: 0. All results are synthetic.

## Change since baseline

- PHQ-9: 7 at baseline, 3 at this visit **S**

## Immunizations given today

- Recombinant zoster vaccine, dose 2 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well; weight 64.2 kg, BMI 24.2; blood pressure 120/76 |
| Eyes | No ptosis after one minute of upgaze; eye movements full |
| Neck | Neck flexion strength 5 of 5; no thyroid enlargement |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Respiratory | Clear; healed port sites on the right chest |
| Breasts | Clinical breast examination declined; not required at her age |
| Abdomen | Soft; both kidneys palpable, non-tender |
| Musculoskeletal | Healed surgical scars on both legs; walks steadily without the cane in the clinic |
| Neurological | Arm abduction held for two minutes without fatigue; speech clear while counting to 50 |
| Skin | No suspicious lesions |
| Psychiatric | Calm, direct and engaged |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic preventive visit completed**. Health risk assessment reviewed and a written prevention plan given. Depression, alcohol and partner-violence screens are negative. On azathioprine and prednisone she should have inactivated vaccines only, and skin protection. **S**
   - Recombinant zoster vaccine dose 2 today.
   - Influenza and COVID-19 vaccines when this season's supply arrives.
   - HIV and hepatitis C screening once, drawn today.
   - Sun protection and a yearly skin check on azathioprine.
   - Next preventive visit in one year.
2. **Generalized myasthenia gravis after thymectomy** (G70.00). Much improved; no ocular or bulbar signs today. **S**
   - Continue the prednisone taper and other medicines as planned by neuromuscular neurology.
   - Show the list of medicines to avoid at every new prescription, including at the dentist.
3. **Autosomal dominant polycystic kidney disease** (Q61.2). Blood pressure 120/76 mm Hg; water intake about 2.5 liters a day. **S**
   - Home blood pressure readings monthly; eGFR and urine albumin at the next review.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 120/76 mm Hg |
| Depression screening | Completed today | PHQ-9 score 3 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 0 |
| Tobacco use | Completed today | Never |
| Intimate partner violence screening | Completed today | Negative; she feels safe at home |
| Cervical cancer screening | Up to date | HPV test two years ago, negative; on long-term immunosuppression the interval will be reviewed with her at the next visit |
| Breast cancer screening | Not indicated | Mammography every two years begins at 40 |
| HIV screening | Ordered | Once for adults 15 to 65; no record of a test; drawn today |
| Hepatitis C screening | Ordered | Once for adults 18 to 79; drawn today with the HIV test |
| Hepatitis B | Up to date | Screened before azathioprine at the second visit: surface antigen and core antibody negative, surface antibody positive from childhood vaccination |
| Pneumococcal vaccine | Up to date | PCV20 at the second visit, before immunosuppression; no further doses needed |
| Recombinant zoster vaccine | Completed today | Dose 2 given today; series complete |
| Influenza vaccine | Due | Inactivated vaccine when this season's supply arrives; no live vaccines on azathioprine |
| COVID-19 vaccine | Due | This season's vaccine in the autumn; she is on immunosuppression |
| Tetanus, diphtheria and pertussis | Up to date | Tdap given in hospital after the crash last year |
| Measles, mumps, rubella and varicella vaccines | Not indicated | Live vaccines are not given on azathioprine and prednisone; immunity to be checked if exposure occurs |
| HPV vaccine | Not indicated | Over 26; shared decision offered for 27 to 45 and not wanted |
| Folic acid | Not indicated | Not planning pregnancy; 0.4 to 0.8 mg daily advised before any planned pregnancy, which should also be planned with neuromuscular neurology because of her medicines |
| Cholesterol screening | Not indicated | Statin screening begins at 40; no diabetes or other indication |
| Bone health on glucocorticoids | Up to date | DXA at the third visit: Z-scores normal; calcium and vitamin D daily |
| Skin cancer prevention | Completed today | Counseled on hat and sunscreen; yearly skin check on azathioprine |

## Advance care planning

Voluntary advance care planning discussion of about 20 minutes, with her consent. She named a health care agent, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. She said that what matters most to her is to keep working for her community, to be told plainly what is happening, and to make her own decisions, with her own Cherokee medicine respected. She chose not to record specific treatment preferences today, and knows that the plan can be updated at any visit. **S**

## Guideline basis

- Sanders DB, et al. International consensus guidance for management of myasthenia gravis: Executive summary. Neurology 2016;87(4):419-425 (2016), Myasthenia Gravis Foundation of America task force (Neurology)
- Adult Immunization Schedule by Medical Condition and Other Indication (2026), Centers for Disease Control and Prevention
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force

## Follow-up

- Seven-month review in seven weeks with neuromuscular neurology input, blood count, liver and kidney tests, hemoglobin A1c and urine albumin. Influenza and COVID-19 vaccines then. Next preventive visit in one year. **S**
- Next scheduled visit 1980-10-12: seven-month review: minimal manifestation status, prednisone and pyridostigmine reduction, azathioprine safety, kidney screening, and plans for the year. **S**
